Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Uterine Cervical Neoplasms × Clear all

NCT07542717 2026-04-21

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Recurrence

NCT07245381 2025-11-24

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07146919 2025-08-28

ANGELICA

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06672653 2024-11-04

PREPAP

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Phase 1/2 Not yet recruiting

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms